Interaction of human stefin B in the prefibrillar oligomeric form with membranes

No abstract is available for this paper.

• Publication year

  2005

• Venue

  The FEBS Journal

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1742-4658.2005.04717.xPMID 15955063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers.

  2005cited by this paper
• Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity*

  2004cited by this paper
• Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.

  2004cited by this paper
• Different propensity to form amyloid fibrils by two homologous proteins—Human stefins A and B: Searching for an explanation

  2004cited by this paper
• Amyloid fibrils from the viewpoint of protein folding

  2004cited by this paper
• Fibrillogenesis and Cytotoxic Activity of the Amyloid-forming Apomyoglobin Mutant W7FW14F*

  2004cited by this paper
• Genome-wide analysis of signaling domain function.

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Unverricht-Lundborg disease with cystatin B gene abnormalities.

  2002cited by this paper
• Two-step Membrane Binding by Equinatoxin II, a Pore-forming Toxin from the Sea Anemone, Involves an Exposed Aromatic Cluster and a Flexible Helix*

  2002cited by this paper
• Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin

  2002cited by this paper
• Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators.

  2002cited by this paper
• Human stefin B readily forms amyloid fibrils in vitro.

  2002cited by this paper
• Amyloid Fibril Formation by Human Stefin B in vitro: Immunogold Labelling and Comparison to Stefin A

  2002cited by this paper
• The channel hypothesis of Alzheimer's disease: current status.

  2002cited by this paper
• Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets.

  2002cited by this paper
• Cytolytic peptide and protein toxins from sea anemones (Anthozoa: Actiniaria).

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• Membrane Targeting by C1 and C2 Domains*

  2001cited by this paper
• Pore formation by beta-2-microglobulin: A mechanism for the pathogenesis of dialysis associated amyloidosis

  2001cited by this paper
• Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease.

  2001cited by this paper
• Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity.

  2001cited by this paper
• Amyloid fibril formation by human stefin B: influence of the initial pH-induced intermediate state.

  2001cited by this paper
• Diversity of Amyloid β Protein Fragment [1–40]-Formed Channels

  2001cited by this paper
• Diversity of amyloid beta protein fragment [1-40]-formed channels.

  2001cited by this paper
• Membrane binding assays for peripheral proteins.

  2001cited by this paper
• The cholesterol-dependent cytolysins.

  2001cited by this paper
• alpha-Synuclein membrane interactions and lipid specificity.

  2000cited by this paper
• Prion peptide fragment PrP[106–126] forms distinct cation channel types

  2000cited by this paper
• Alzheimer's β-Amyloid, Human Islet Amylin, and Prion Protein Fragment Evoke Intracellular Free Calcium Elevations by a Common Mechanism in a Hypothalamic GnRH Neuronal Cell Line*

  2000cited by this paper
• α-Synuclein Membrane Interactions and Lipid Specificity*

  2000cited by this paper
• Amyloid fibrillogenesis: themes and variations.

  2000cited by this paper
• Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

  1999cited by this paper
• Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

  1999cited by this paper
• Protein misfolding, evolution and disease.

  1999cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Amyloid fibril formation by an SH3 domain.

  1998cited by this paper
• Filamentous nerve cell inclusions in neurodegenerative diseases.

  1998cited by this paper
• Channel Formation by a Neurotoxic Prion Protein Fragment*

  1997cited by this paper
• Characterization of the equilibrium intermediates in acid denaturation of human stefin B.

  1997cited by this paper
• Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*)

  1996cited by this paper
• Zn2+ interaction with Alzheimer amyloid beta protein calcium channels.

  1996cited by this paper
• β-amyloid Ca2+-channel hypothesis for neuronal death in Alzheimer Disease

  1994cited by this paper
• beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease.

  1994cited by this paper
• Improved expression and evaluation of polyethyleneimine precipitation in isolation of recombinant cysteine proteinase inhibitor stefin B.

  1994cited by this paper
• Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes.

  1993cited by this paper
• Intermediates in denaturation of a small globular protein, recombinant human stefin B.

  1992cited by this paper
• Small-volume extrusion apparatus for preparation of large, unilamellar vesicles.

  1991cited by this paper
• Cystatin C mutation causing amyloid angiopathy and brain hemorrhage.

  1990cited by this paper
• Cloning a synthetic gene for human stefin B and its expression in E. coli

  1988cited by this paper
• Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers.

  1975cited by this paper
• Zn 2 + interaction with Alzheimer amyloid ( 3 protein calcium channels

  year unknowncited by this paper

• Supramolecular Assembly of Lanthanide-Binding Tag Peptides for Aqueous Separation of Rare Earth Elements

  2025cites this paper
• Inhibitory effect of saffron components on hIAPP fibrils formation; a molecular dynamics simulation study

  2024cites this paper
• Protein Condensates and Protein Aggregates: In Vitro, in the Cell, and In Silico.

  2023cites this paper
• Human stefin B: from its structure, folding, and aggregation to its function in health and disease

  2022cites this paper
• Antioxidants From the Class of Polyphenols, NAC and Vitamin C Act Differently on Amyloid Fibril Formation by Two Human Cystatins: Stefin B and Cystatin C.

  2020cites this paper
• Protein Self-Assembly: Methods and Protocols

  2019cites this paper
• Possible Mechanisms by which Stefin B could Regulate Proteostasis and Oxidative Stress

  2019cites this paper
• Atomistic Simulation Tools to Study Protein Self-Aggregation.

  2019cites this paper
• Chapter 10 Structure and Function of Stefin B Oligomers – Important Role in

  2017cites this paper
• Polyphenols protect mitochondrial membrane against permeabilization induced by HEWL oligomers: Possible mechanism of action.

  2017cites this paper
• Quantification of Protein-Lipid Interaction Exemplified for SecA Protein

  2017cites this paper
• Interactions of Lipid Membranes with Fibrillar Protein Aggregates.

  2015cites this paper
• On Possible Function and Toxicity of Multiple Oligomeric/Conformational States of a Globular Protein – Human Stefin B

  2014cites this paper
• Structure and Function of Stefin B Oligomers – Important Role in Amyloidogenesis

  2014cites this paper
• Human Stefin B Role in Cell's Response to Misfolded Proteins and Autophagy

  2014cites this paper
• Probing the interplay between amyloidogenic proteins and membranes using lipid monolayers and bilayers.

  2014cites this paper
• Coarse-Grained Molecular Dynamics Simulations of Peptide Aggregation on Surfaces

  2014cites this paper
• Amyloid fibrils are nanoparticles that target lysosomes.

  2014cites this paper
• The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B

  2013cites this paper
• as an example of the indoor extreme environment for survival and propagation of Exophiala dermatitidis and E. phaeomuriformis

  2013cites this paper
• The oligomer species: mechanistics and biochemistry

  2013cites this paper
• β-sheet propensity controls the kinetic pathways and morphologies of seeded peptide aggregation.

  2012cites this paper
• The effect of lysozyme amyloid fibrils on cytochrome c-lipid interactions.

  2012cites this paper
• Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants

  2012influential citation
• Pore formation by human stefin B in its native and oligomeric states and the consequent amyloid induced toxicity

  2012cites this paper
• Increased expression of stefin B in the nucleus of T98G astrocytoma cells delays caspase activation

  2012influential citation
• Amyloids here, amyloids there…What’s wrong with them?

  2012cites this paper
• Pore formation by human stefin B in its native and oligomeric states and the consequent amyloid induced toxicity

  2012cites this paper
• Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants

  2012cites this paper
• Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits.

  2012cites this paper
• The cross-road between the mechanisms of protein folding and aggregation; study of human stefin B and its H75W mutant.

  2011cites this paper
• Effects of oligomeric lysozyme on structural state of model membranes.

  2011cites this paper
• Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.

  2011cites this paper
• The key role of membranes in amyloid formation from a biophysical perspective.

  2011cites this paper
• Evaluation of protein aggregation and organismal fitness

  2011cites this paper
• Intracellular aggregation of human stefin B: confocal and electron microscopy study

  2010cites this paper
• Binding of amyloid peptides to domain-swapped dimers of other amyloid-forming proteins may prevent their neurotoxicity.

  2010cites this paper
• Amyloid fibril formation by human stefins: Structure, mechanism & putative functions.

  2010cites this paper
• Protein conformational pathology in Alzheimer's and other neurodegenerative diseases; new targets for therapy.

  2009cites this paper
• Hen lysozyme amyloid fibrils induce aggregation of erythrocytes and lipid vesicles

  2009cites this paper
• The two-fold aspect of the interplay of amyloidogenic proteins with lipid membranes.

  2009cites this paper
• Interaction between Oligomers of Stefin B and Amyloid-β in Vitro and in Cells*

  2009cites this paper
• Surface chemistry of Alzheimer's disease: a Langmuir monolayer approach.

  2009cites this paper
• Mistic: Cellular localization, solution behavior, polymerization, and fibril formation

  2009cites this paper
• Essential role of Pro 74 in stefin B amyloid‐fibril formation: Dual action of cyclophilin A on the process

  2009cites this paper
• Interaction with model membranes and pore formation by human stefin B – studying the native and prefibrillar states

  2008influential citation
• USING STEFIN B AS A MODEL AMYLOIDOGENIC PROTEIN –OVERVIEW

  2008cites this paper
• Size and morphology of toxic oligomers of amyloidogenic proteins: a case study of human stefin B

  2008cites this paper
• Differentiation Increases the Resistance of Neuronal Cells to Amyloid Toxicity

  2008cites this paper
• Similar toxicity of the oligomeric molten globule state and the prefibrillar oligomers

  2008cites this paper
• Amyloid fibril formation by human stefin B: influence of pH and TFE on fibril growth and morphology

  2007cites this paper
• Structural studies of heterogeneous amyloid species of lysozymes and de novo protein albebetin and their cytotoxicity

  2007cites this paper
• Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways.

  2007cites this paper
• Self-assembly of human latexin into amyloid-like oligomers

  2007cites this paper
• Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases

  2007cites this paper
• High affinity copper binding by stefin B (cystatin B) and its role in the inhibition of amyloid fibrillation

  2006cites this paper
• AMILOIDNA FIBRILACIJA IN INTERAKCIJA Z LIPIDNIMI MEMBRANAMI ČLOVEŠKEGA STEFINA B IN IZBRANIH MUTANT IN VITRO

  2006cites this paper
• Survey of the year 2005 commercial optical biosensor literature

  2006cites this paper
• Cytotoxicity of albebetin oligomers depends on cross‐β‐sheet formation

  2006cites this paper
• Surface plasmon resonance in protein-membrane interactions.

  2006influential citation
• Protein aggregation and amyloidosis: confusion of the kinds?

  2006cites this paper
• Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers.

  2006cites this paper
• Cytotoxicity of albebetin oligomers depends on cross-beta-sheet formation.

  2006cites this paper
• Survey of the year 2003 commercial optical biosensor literature

  2005cites this paper
• In vitro study of stability and amyloid‐fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1

  2005cites this paper